Dashboard
Manage Tickers

ARAY ACCURAY INC

Nasdaq accuray.com


$ 1.70 $ 0.00 (0 %)    

Monday, 20-Oct-2025 18:42:47 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 612.11 $ 7.61 (1.26 %)
DIA $ 467.12 $ 5.24 (1.13 %)
SPY $ 671.75 $ 6.91 (1.04 %)
TLT $ 91.68 $ 0.35 (0.38 %)
GLD $ 401.36 $ 14.16 (3.64 %)
$ 1.69
$ 1.64
$ 1.67 x 20
$ 1.72 x 5,205
$ 1.63 - $ 1.79
$ 1.14 - $ 2.95
1,025,546
na
190.42M
$ 1.60
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-28-2025 06-30-2025 10-K
2 05-02-2025 03-31-2025 10-Q
3 02-05-2025 12-31-2024 10-Q
4 11-06-2024 09-30-2024 10-Q
5 09-19-2024 06-30-2024 10-K
6 05-08-2024 03-31-2024 10-Q
7 02-07-2024 12-31-2023 10-Q
8 11-07-2023 09-30-2023 10-Q
9 09-07-2023 06-30-2023 10-K
10 05-08-2023 03-31-2023 10-Q
11 02-02-2023 12-31-2022 10-Q
12 11-03-2022 09-30-2022 10-Q
13 08-17-2022 06-30-2022 10-K
14 04-29-2022 03-31-2022 10-Q
15 01-28-2022 12-31-2021 10-Q
16 11-04-2021 09-30-2021 10-Q
17 08-17-2021 06-30-2021 10-K
18 04-30-2021 03-31-2021 10-Q
19 02-01-2021 12-31-2020 10-Q
20 11-04-2020 09-30-2020 10-Q
21 08-25-2020 06-30-2020 10-K
22 05-08-2020 03-31-2020 10-Q
23 02-04-2020 12-31-2019 10-Q
24 11-06-2019 09-30-2019 10-Q
25 08-23-2019 06-30-2019 10-K
26 05-09-2019 03-31-2019 10-Q
27 02-08-2019 12-31-2018 10-Q
28 11-06-2018 09-30-2018 10-Q
29 08-24-2018 06-30-2018 10-K
30 05-02-2018 03-31-2018 10-Q
31 02-05-2018 12-31-2017 10-Q
32 11-03-2017 09-30-2017 10-Q
33 08-25-2017 06-30-2017 10-K
34 05-05-2017 03-31-2017 10-Q
35 02-03-2017 12-31-2016 10-Q
36 11-01-2016 09-30-2016 10-Q
37 08-24-2016 06-30-2016 10-K
38 04-29-2016 03-31-2016 10-Q
39 02-01-2016 12-31-2015 10-Q
40 11-05-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

accuray-reports-preliminary-q1-fy26-revenue-of-925m-94m-product-sales-lag-in-eimea-and-china-ebitda-at-4m
Accuray Reports Preliminary Q1 FY26 Revenu...
10/20/2025 13:23:26

Fiscal 2026 First Quarter Financial ResultsAccuray expects to release summary financial information for its fiscal 2026 first q...

accuray-appoints-steve-la-neve-as-ceo-effective-immediately-succeeding-suzanne-winter
Accuray Appoints Steve La Neve As CEO, Eff...
10/20/2025 13:23:19

Accuray Incorporated (NASDAQ: ARAY) today announced it is engaging in a significant organizational, strategic, and operational ...

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
10/10/2025 12:07:59

accuray-announces-first-patients-treated-through-5d-clinics-in-melbourne-using-cyberknife-s7-system
Accuray Announces First Patients Treated T...
10/08/2025 11:44:15

5D Clinics and Joint Venture Partner Icon Group Make Strides in Delivering on Commitment to Increasing Access to World-class Ra...

accuray-and-uw-smph-sign-mou-to-advance-online-adaptive-radiotherapy-on-accuray-helical-radiation-treatment-delivery-platform
Accuray And UW SMPH Sign MOU To Advance On...
09/30/2025 11:38:19

Accuray Incorporated (NASDAQ:ARAY) and the University of Wisconsin School of Medicine and Public Health (UW SMPH) announced tod...

accuray-inc-advances-adaptive-radiotherapy-with-introduction-of-accuray-stellar-solution
Accuray Inc. Advances Adaptive Radiotherap...
09/26/2025 11:36:48

New Solution Provides an Unprecedented Set of Tools, Empowering Clinical Teams With Choice and Flexibility to Deliver Adaptive ...

btig-maintains-buy-on-accuray-raises-price-target-to-5
BTIG Maintains Buy on Accuray, Raises Pric...
08/14/2025 12:20:13

BTIG analyst Maria Thibault maintains Accuray (NASDAQ:ARAY) with a Buy and raises the price target from $4 to $5.

accuray-sees-fy2026-sales-471000m-485000m-vs-454740m-est
Accuray Sees FY2026 Sales $471.000M-$485.0...
08/13/2025 20:10:14

Accuray (NASDAQ:ARAY) sees FY2026 sales of $471.000 million-$485.000 million vs $454.740 million analyst estimate.

accuray-q4-eps-001-misses-002-estimate-sales-127543m-beat-123774m-estimate
Accuray Q4 EPS $0.01 Misses $0.02 Estimate...
08/13/2025 20:09:44

Accuray (NASDAQ:ARAY) reported quarterly earnings of $0.01 per share which missed the analyst consensus estimate of $0.02 by 44...

Core News & Articles
Earnings Scheduled For August 13, 2025
08/13/2025 08:32:30

a-glimpse-of-accurays-earnings-potential
A Glimpse of Accuray's Earnings Potential
08/12/2025 17:02:11

Core News & Articles
12 Health Care Stocks Moving In Friday's I...
06/06/2025 17:06:47

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
06/06/2025 12:07:07

accuray-to-exchange-82m-of-375-convertible-notes-for-888m-shares-and-686m-cash-in-debt-reduction-deal-closing-june-11
Accuray To Exchange $82M Of 3.75% Converti...
06/06/2025 11:38:26

accuray-announces-that-new-data-presented-at-the-european-society-for-radiotherapy-and-oncology-meeting-reinforces-the-benefits-of-the-companys-cyberknife-system-in-the-treatment-of-prostate-cancer-at-multiple-stages-of-the-cancer-journey
Accuray Announces That New Data Presented ...
05/07/2025 11:36:15

accuray-reports-first-srssbrt-patient-treatments-in-austria-with-the-cyberknife-system
Accuray Reports First SRS/SBRT Patient Tre...
05/05/2025 20:42:36

accuray-lowers-fy2025-sales-guidance-from-46300m-47500m-to-45200m-46000m-vs-46830m-est
Accuray Lowers FY2025 Sales Guidance from ...
04/30/2025 20:25:29

Accuray (NASDAQ:ARAY) lowers FY2025 sales outlook from $463.00 million-$475.00 million to $452.00 million-$460.00 million vs $4...

accuray-q3-eps-001-beats-005-estimate-sales-11324m-beat-10153m-estimate
Accuray Q3 EPS $(0.01) Beats $(0.05) Estim...
04/30/2025 20:13:54

Accuray (NASDAQ:ARAY) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.05) by 80...

Core News & Articles
Earnings Scheduled For April 30, 2025
04/30/2025 08:32:41

insights-ahead-accurays-quarterly-earnings
Insights Ahead: Accuray's Quarterly Earnings
04/29/2025 21:01:50

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION